Phase II clinical trial of oxaliplatin and bevacizumab in refractory metastatic germ cell tumors (GCT).
A. Jain
No relevant relationships to disclose
M. J. Brames
No relevant relationships to disclose
D. J. Vaughn
No relevant relationships to disclose
L. H. Einhorn
No relevant relationships to disclose